ORIGINAL ARTICLE |
|
Year : 2022 | Volume
: 13
| Issue : 1 | Page : 157 |
|
The association of opioid use disorder and COVID-19, a longitudinal study
Zhaleh Jamali1, Mohammad Hassan Emamian2, Hassan Hashemi3, Akbar Fotouhi4
1 Student Research Committee, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran 2 Ophthalmic Epidemiology Research Center, Shahroud University of Medical Sciences, Shahroud, Iran 3 Noor Ophthalmology Research Center, Noor Eye Hospital, Tehran, Iran 4 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Correspondence Address:
Mohammad Hassan Emamian 7 Tir SQ, Shahroud University of Medical Sciences, Shahroud Iran
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/ijpvm.ijpvm_68_22
|
|
Background: Coronavirus disease 2019 (COVID-19) quickly spread to the world, causing a pandemic. While some studies have found no link between opioid use disorder (OUD) and COVID-19, the role of opioid on COVID-19 is challenging. The present study aimed to determine the relationship between OUD and COVID-19. Methods: This was a prospective cohort study. We used data from the third phase of the Shahroud Eye Cohort Study on 4394 participants which started in September 2019 and ended before the COVID-19 epidemic in Shahroud in February 2020. The participants were followed for about 13 months till March 26, 2021. COVID-19 was detected by RT-PCR on swap samples from the oropharynx and nasopharynx. The incidence of COVID-19 compared in OUD and non-OUD participants, and relative risk was calculated in log-binomial regression models. Results: Among the 4394 participants with a mean age of 61.1 years, 120 people had OUD. The incidence of COVID-19 in participants with OUD and non-OUD was 4.17% and 6.22%, respectively (P-value: 0356). The relative risk of OUD for COVID-19 was 0.60 (95% confidence intervals: 0.25–1.44; P value: 0.251). Conclusions: OUD was not associated with COVID-19. The claim that people with OUD are less likely to develop COVID-19 is not supported by these data.
|
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|